GOLDMAN SACHS GROUP INC - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 45 filers reported holding NEON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$36,000
-47.1%
13,771
-76.2%
0.00%
Q4 2019$68,000
-12.8%
57,814
+27.3%
0.00%
Q3 2019$78,000
-68.2%
45,418
-12.2%
0.00%
Q2 2019$245,000
+25.0%
51,750
+70.4%
0.00%
Q1 2019$196,000
+151.3%
30,377
+94.9%
0.00%
Q4 2018$78,000
-90.1%
15,587
-75.1%
0.00%
Q2 2018$788,00062,5000.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$25,718,0007.00%
HARVARD MANAGEMENT CO INC 505,871$1,335,0000.21%
ARMISTICE CAPITAL, LLC 1,050,000$2,772,0000.17%
Maven Securities LTD 381,150$1,006,0000.12%
Athanor Capital, LP 547,651$1,446,0000.09%
MONETA GROUP INVESTMENT ADVISORS LLC 102,652$271,0000.03%
TERRIL BROTHERS, INC. 19,300$51,0000.02%
MEEDER ASSET MANAGEMENT INC 5,878$15,0000.00%
ACADIAN ASSET MANAGEMENT LLC 94,908$251,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEON THERAPEUTICS INC shareholders